Among the 17 suggested drug targets for RA, dihydroorotate dehydrogenase (DHODH) and Acetyl-CoA acetyltransferase (ACAT1) have already been explored as targets in drug development efforts42,43, and 15 genes were newly identified. The gene discussed is ACAA2; the disease is rheumatoid arthritis.